Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol

Joint Authors

Barold, S. Serge
Upton, Scott

Source

Case Reports in Cardiology

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-10-15

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency.

The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when the agent was discontinued.

However, the potassium level rose again to 5.6 mEq/L after the administration of carvedilol but the level normalized by halving the dose.

The observations of hyperkalemia induced by two different β-blocker drugs in the same patient confirm that this side effect is common to all β-blocker drugs.

American Psychological Association (APA)

Barold, S. Serge& Upton, Scott. 2018. Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol. Case Reports in Cardiology،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1141298

Modern Language Association (MLA)

Barold, S. Serge& Upton, Scott. Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol. Case Reports in Cardiology No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1141298

American Medical Association (AMA)

Barold, S. Serge& Upton, Scott. Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol. Case Reports in Cardiology. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1141298

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1141298